{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "A healthy 28-year-old with concerns about diseases in her family had three different companies check her genetic code. The discrepancies in their results were striking.", "headline": {"main": "I Had My DNA Picture Taken, With Varying Results", "print_headline": "I Had My DNA Picture Taken"}, "abstract": "Keira Peikoff, healthy 28-year-old with concerns about diseases in her family, enlists companies 23andMe, Genetic Testing Laboratories and Pathway Genomics to check her genetic code; finds striking discrepancies in their results.", "print_page": "1", "word_count": "1530", "_id": "52c19af779881043c1e4883f", "snippet": "A healthy 28-year-old with concerns about diseases in her family had three different companies check her genetic code. The discrepancies in their results were striking.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2013/12/31/science/i-had-my-dna-picture-taken-with-varying-results.html", "multimedia": [{"width": 190, "url": "images/2013/12/31/science/31DNA_SPAN/31DNA_SPAN-thumbWide-v2.jpg", "height": 126, "subtype": "wide", "legacy": {"wide": "images/2013/12/31/science/31DNA_SPAN/31DNA_SPAN-thumbWide-v2.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"width": 600, "url": "images/2013/12/31/science/31DNA_SPAN/31DNA-articleLarge.jpg", "height": 399, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlarge": "images/2013/12/31/science/31DNA_SPAN/31DNA-articleLarge.jpg", "xlargeheight": "399"}, "type": "image"}, {"width": 75, "url": "images/2013/12/31/science/31DNA_SPAN/31DNA_SPAN-thumbStandard-v3.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2013/12/31/science/31DNA_SPAN/31DNA_SPAN-thumbStandard-v3.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"rank": "5", "is_major": "Y", "value": "Genetic Testing Laboratories", "name": "organizations"}, {"rank": "7", "is_major": "Y", "value": "Medicine and Health", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "DNA (Deoxyribonucleic Acid)", "name": "subject"}, {"rank": "6", "is_major": "Y", "value": "Pathway Genomics", "name": "organizations"}, {"rank": "1", "is_major": "Y", "value": "Genetics and Heredity", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Tests (Medical)", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "23andMe", "name": "organizations"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "firstname": "Kira", "rank": 1, "lastname": "PEIKOFF"}], "original": "By KIRA PEIKOFF"}, "document_type": "article", "pub_date": "2013-12-31T00:00:00Z", "section_name": "Science"}, {"type_of_material": "News", "blog": [], "news_desk": "Foreign", "lead_paragraph": "The government has threatened to allow production of less costly versions of a breast cancer treatment, a move the pharmaceutical industry says threatens the system for discovering cures.", "headline": {"main": "India\u2019s Efforts to Aid Poor Worry Drug Makers", "kicker": "The Cancer Divide", "print_headline": "India\u2019s Efforts to Aid Poor Worry Drug Makers", "content_kicker": "The Cancer Divide"}, "abstract": "Indian government, in effort to help poor, is pushing to allow less costly, generic versions of cancer medicines, but move is seen by pharmaceutical industry as threat to global system for discovering cures; health advocates say that similar arguments were made by industry and United States government as they sought to protect patents on AIDS medicines in 1990s (Series: The Cancer Divide).", "print_page": "1", "word_count": "1740", "_id": "52c0dda079881043c1e486ba", "snippet": "The government has threatened to allow production of less costly versions of a breast cancer treatment, a move the pharmaceutical industry says threatens the system for discovering cures.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2013/12/30/health/indias-efforts-to-aid-poor-worry-drugmakers.html", "multimedia": [{"subtype": "wide", "url": "images/2013/12/29/world/asia/CANCER-section-front/20131230-CANCER-slide-JLW1-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2013/12/29/world/asia/CANCER-section-front/20131230-CANCER-slide-JLW1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2013/12/29/world/asia/CANCER-section-front/20131230-CANCER-slide-JLW1-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2013/12/29/world/asia/CANCER-section-front/20131230-CANCER-slide-JLW1-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2013/12/29/world/asia/CANCER-section-front/20131230-CANCER-slide-JLW1-thumbStandard-v3.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2013/12/29/world/asia/CANCER-section-front/20131230-CANCER-slide-JLW1-thumbStandard-v3.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Breast Cancer", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "India", "is_major": "Y", "rank": "3", "name": "glocations"}, {"value": "Cancer", "is_major": "Y", "rank": "4", "name": "subject"}, {"value": "Herceptin (Drug)", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Generic Brands and Products", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "Series", "is_major": "Y", "rank": "8", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gardiner", "lastname": "HARRIS"}], "original": "By GARDINER HARRIS"}, "document_type": "article", "pub_date": "2013-12-30T00:00:00Z", "section_name": "Health"}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "", "headline": {"main": "When Bacteria Can No Longer Be Stopped", "kicker": "Room For Debate"}, "abstract": "How we can avoid a future where antibiotics are no longer useful?", "print_page": null, "word_count": "3254", "_id": "52c0d09a79881043c1e48696", "snippet": "How we can avoid a future where antibiotics are no longer useful?", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/roomfordebate/2013/12/29/avoiding-a-time-when-bacteria-can-no-longer-be-stopped/", "multimedia": [], "subsection_name": "Room For Debate", "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}], "byline": null, "document_type": "blogpost", "pub_date": "2013-12-29T19:00:00Z", "section_name": "Opinion"}], "meta": {"hits": 3, "offset": 0, "time": 54}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}